Annals of Hematology

SJR Rank #7,114H-index: 98SJR: 0.784Best quartile: Q2Open AccessAPC: US$4,590Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media Deutschland GmbH

Country

Germany

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • HematologyQ2
  • Medicine (miscellaneous)Q2

Areas: Medicine

Most published research topics

Acute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchHematopoietic Stem Cell TransplantationHemoglobinopathies and Related DisordersMyeloproliferative Neoplasms: Diagnosis and TreatmentChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchBlood groups and transfusionMultiple Myeloma Research and Treatments

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs040080012001600

Documents per Year

202220250200400600800

Detailed Information

ISSN

1432-0584, 0939-5555

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

1.97

References per Document

34.45

Coverage

1991-2026

Scope

A forum for clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of hematological oncology Also covers diagnosis and treatment of leukemias, lymphatic neoplasias and transplantation of hematopoietic stem cells Examines relevant aspects of oncology, molecular biology and immunology 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again Annals of Hematology covers the whole spectrum of clinical and translational hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.

Metrics from SCImago Journal Rank 2025. View on SCImago